Evan Loh, President, COO and CMO at Paratek Pharmaceuticals, Inc. (PRTK), sold 11,525 shares at $6.27 ($75K) on 2018-12-13, disclosed to the SEC on 2018-12-14.
Scheduled sale ($75k) by President, COO and CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.76 | 5,525 | $37K | 49.8% |
| 2 | $6.27 | 6,000 | $38K | 50.2% |
| Total | $6.50 avg | 11,525 | $75K | 100% |
| Filing → |
| PRTK | SELL | 2022-12-14 | $393K | — | Filing → |
| PRTK | SELL | 2022-11-01 | $31K | — | Filing → |
| PRTK | SELL | 2022-08-10 | $237K | — | Filing → |